Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Coagulation Factor VIII On-demand Treatment in Hemophilia A
CTR20221674Phase 3Completed
- Sponsor
- Hebei Da'an Pharmaceutical
- Start
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antihemophilic factor human in hemophilia A, sponsored by Hebei Da'an Pharmaceutical. Started Nov 2022; status: completed.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20221674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221674.